Ttbio Corp. (TPEX:6493)
Taiwan · Delayed Price · Currency is TWD 38.40
+0.20 (0.52%)
Sep 8, 2026, 12:18 PM CST
Ttbio Market Cap
Ttbio has a market cap or net worth of 901.88 million as of September 8, 2026. Its market cap has decreased by -37.47% in one year.
Market Cap
901.88M
Enterprise Value
879.14M
Revenue
433.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.40
ChartMarket Cap Chart
Since January 8, 2015, Ttbio's market cap has decreased from 1.19B to 901.88M, a decrease of -24.24%. That is a compound annual growth rate of -2.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 1.15B | 40.96% |
| Dec 31, 2025 | 814.36M | 70.16% |
| Dec 30, 2024 | 478.60M | -8.92% |
| Dec 26, 2023 | 525.49M | -19.22% |
| Dec 28, 2022 | 650.55M | 21.30% |
| Dec 30, 2021 | 536.32M | 2.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ICARES Medicus | 3.67B |
| SciVision Biotech | 3.52B |
| Maxigen Biotech | 3.43B |
| Nang Kuang Pharmaceutical | 3.22B |
| Crystalvue Medical | 1.88B |
| BenQ Medical Technology | 1.79B |
| Chi Sheng Pharma & Biotech | 1.72B |
| Lagis Enterprise | 1.19B |